Tumor-Treating Fields: A Fourth Modality in Cancer Treatment von Mun, Elijah J, Babiker, Hani M, Weinberg, Uri, Kirson, Eilon D, Von Hoff, Daniel D

Volltext

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma von Provenzano, Paolo P., Cuevas, Carlos, Chang, Amy E., Goel, Vikas K., Von Hoff, Daniel D., Hingorani, Sunil R.

Volltext

Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells von Bapat, Aditi A, Munoz, Ruben M, Von Hoff, Daniel D, Han, Haiyong

Volltext

Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer von Whatcott, Clifford J, Ng, Serina, Barrett, Michael T, Hostetter, Galen, Von Hoff, Daniel D, Han, Haiyong

Volltext

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors von Wang-Gillam, Andrea, Hubner, Richard A., Siveke, Jens T., Von Hoff, Daniel D., Belanger, Bruce, de Jong, Floris A., Mirakhur, Beloo, Chen, Li-Tzong

Volltext

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells von Diep, Caroline H, Zucker, Kelly M, Hostetter, Galen, Watanabe, Aprill, Hu, Chengcheng, Munoz, Ruben M, Von Hoff, Daniel D, Han, Haiyong

Volltext

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer von Whatcott, Clifford J, Diep, Caroline H, Jiang, Ping, Watanabe, Aprill, LoBello, Janine, Sima, Chao, Hostetter, Galen, Shepard, H Michael, Von Hoff, Daniel D, Han, Haiyong

Volltext

Tumor-stroma interactions in pancreatic ductal adenocarcinoma von Mahadevan, Daruka, Von Hoff, Daniel D

Volltext

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial von Bockorny, Bruno, Semenisty, Valerya, Macarulla, Teresa, Borazanci, Erkut, Wolpin, Brian M., Stemmer, Salomon M., Golan, Talia, Geva, Ravit, Borad, Mitesh J., Pedersen, Katrina S., Park, Joon Oh, Ramirez, Robert A., Abad, David G., Feliu, Jaime, Muñoz, Andres, Ponz-Sarvise, Mariano, Peled, Amnon, Lustig, Tzipora M., Bohana-Kashtan, Osnat, Shaw, Stephen M., Sorani, Ella, Chaney, Marya, Kadosh, Shaul, Vainstein Haras, Abi, Von Hoff, Daniel D., Hidalgo, Manuel

Volltext

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine von Von Hoff, Daniel D, Ervin, Thomas, Arena, Francis P, Chiorean, E. Gabriela, Infante, Jeffrey, Moore, Malcolm, Seay, Thomas, Tjulandin, Sergei A, Ma, Wen Wee, Saleh, Mansoor N, Harris, Marion, Reni, Michele, Dowden, Scot, Laheru, Daniel, Bahary, Nathan, Ramanathan, Ramesh K, Tabernero, Josep, Hidalgo, Manuel, Goldstein, David, Van Cutsem, Eric, Wei, Xinyu, Iglesias, Jose, Renschler, Markus F

Volltext

Perineural invasion and associated pain in pancreatic cancer von Bapat, Aditi A., Hostetter, Galen, Von Hoff, Daniel D., Han, Haiyong

Volltext

Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma von De Jesus-Acosta, Ana, Sugar, Elizabeth A., O’Dwyer, Peter J., Ramanathan, Ramesh K., Von Hoff, Daniel D., Rasheed, Zeshaan, Zheng, Lei, Begum, Asma, Anders, Robert, Maitra, Anirban, McAllister, Florencia, Rajeshkumar, N. V., Yabuuchi, Shinichi, de Wilde, Roeland F., Batukbhai, Bhavina, Sahin, Ismet, Laheru, Daniel A.

Volltext

Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial von Von Hoff, Daniel D, Ramanathan, Ramesh K, Borad, Mitesh J, Laheru, Daniel A, Smith, Lon S, Wood, Tina E, Korn, Ronald L, Desai, Neil, Trieu, Vuong, Iglesias, Jose L, Zhang, Hui, Soon-Shiong, Patrick, Shi, Tao, Rajeshkumar, N V, Maitra, Anirban, Hidalgo, Manuel

Volltext

Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions von Lin, Wei, Noel, Pawan, Borazanci, Erkut H, Lee, Jeeyun, Amini, Albert, Han, In Woong, Heo, Jin Seok, Jameson, Gayle S, Fraser, Cory, Steinbach, Margaux, Woo, Yanghee, Fong, Yuman, Cridebring, Derek, Von Hoff, Daniel D, Park, Joon Oh, Han, Haiyong

Volltext

Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer von Jameson, Gayle S., Hosein, Peter J., Pierce, Erin, Kamgar, Mandana, Gordon, Michael S., Snyder, Courtney, Roe, Denise J., Wertheim, Betsy C., Davey, Marina, Barrett, Michael T., Von Hoff, Daniel D., Borazanci, Erkut

Volltext

Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas von HIDALGO, Manuel, VON HOFF, Daniel D

Volltext

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges von Weiss, Glen J, Liang, Winnie S, Demeure, Michael J, Kiefer, Jeff A, Hostetter, Galen, Izatt, Tyler, Sinari, Shripad, Christoforides, Alexis, Aldrich, Jessica, Kurdoglu, Ahmet, Phillips, Lori, Benson, Hollie, Reiman, Rebecca, Baker, Angela, Marsh, Vickie, Von Hoff, Daniel D, Carpten, John D, Craig, David W

Volltext

Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression von Li, Xiaoming, Shepard, H Michael, Cowell, Jessica A, Zhao, Chunmei, Osgood, Ryan J, Rosengren, Sanna, Blouw, Barbara, Garrovillo, Sheryl A, Pagel, Mark D, Whatcott, Clifford J, Han, Haiyong, Von Hoff, Daniel D, Taverna, Darin M, LaBarre, Michael J, Maneval, Daniel C, Thompson, Curtis B

Volltext

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers von VON HOFF, Daniel D, STEPHENSON, Joseph J, FITCH, Tom R, WASSERMAN, Ernesto, FERNANDEZ, Cristian, GREEN, Sylvan, SUTHERLAND, William, BITTNER, Michael, ALARCON, Arlet, MALLERY, David, PENNY, Robert, ROSEN, Peter, LOESCH, David M, BORAD, Mitesh J, ANTHONY, Stephen, JAMESON, Gayle, BROWN, Susan, CANTAFIO, Nina, RICHARDS, Donald A

Volltext

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer von Azorsa, David O, Gonzales, Irma M, Basu, Gargi D, Choudhary, Ashish, Arora, Shilpi, Bisanz, Kristen M, Kiefer, Jeffrey A, Henderson, Meredith C, Trent, Jeffrey M, Von Hoff, Daniel D, Mousses, Spyro

Volltext